Hudson Bay Capital Management LP

Position in IMCR — Immunocore Holdings plc

CIK 1393825 STAMFORD, CT

Position in IMCR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$19,090,196

+$5,776,898 QoQ

Shares Held

633,174

+65.1% QoQ

Ownership

1.24%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Hudson Bay Capital Management LP holds $534,286,565 across 150 Biotechnology names. IMCR ranks #8 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	974,776	$55,065,096
2	APLS	Apellis Pharmaceuticals, Inc.	1,190,416	$47,890,435
3	REGN	Regeneron Pharmaceuticals, Inc.	32,001	$24,725,252
4	BNTX	BioNTech SE	275,000	$24,442,000
5	IONS	Ionis Pharmaceuticals Inc	295,100	$22,159,059
6	ARGX	Argenx SE	30,000	$21,907,500
7	VRTX	Vertex Pharmaceuticals Inc / Ma	45,000	$20,094,300
8	IMCR	Immunocore Holdings plc This page	633,174	$19,090,196

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,090,196	633,174	+65.1%	Shares	Sole	2026-05-13
2025-12-31	$13,313,298	383,558	+15.0%	Shares	Sole	2026-02-13
2025-09-30	$12,118,162	333,558	-3.6%	Shares	Sole	2025-12-15
2025-06-30	$10,855,973	345,952	-12.5%	Shares	Sole	2025-08-18
2025-03-31	$11,729,559	395,334	+21.5%	Shares	Sole	2025-05-14
2024-12-31	$9,596,350	325,300	+31.5%	Shares	Sole	2025-02-14
2024-09-30	$7,698,449	247,300	+28.0%	Shares	Sole	2024-11-13
2024-06-30	$6,546,836	193,179	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.